Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar Lonial

Showing results (61-70 of 440) with videos related to

Pageof 44
Sort By:
CA: a Cancer Journal for Clinicians|January 10, 2023
Chimeric antigen receptor T-cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practiceRujul H Parikh, Sagar Lonial
Cancer|May 19, 2016
Death by a thousand cuts: the slow demise of chemotherapyAjay K Nooka, Sagar Lonial
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
The era of combination therapy in myelomaSagar Lonial, Jonathan L Kaufman
Biologics : Targets & Therapy|February 13, 2016
Emerging treatments in Castleman disease - a critical appraisal of siltuximabJean L Koff, Sagar Lonial
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Novel drug combinations for the management of relapsed/refractory multiple myelomaSaad Z Usmani, Sagar Lonial
Current Opinion in Oncology|September 5, 2020
Practical approach to the management of smoldering myelomaNisha S Joseph, Sagar Lonial
Current Hematologic Malignancy Reports|May 8, 2010
Improving induction therapy in multiple myelomaAjay Nooka, Charise Gleason, Sagar Lonial
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2013
Induction therapy for newly diagnosed multiple myelomaSagar Lonial, Jesus F San Miguel
Current Hematologic Malignancy Reports|April 29, 2010
Treatment of relapsed and refractory myelomaJonathan Kaufman, Charise Gleason, Sagar Lonial
Journal of the National Medical Association|December 24, 2022
Disparities in multiple myeloma among African AmericansManisha Bhutani, Sagar Lonial, Joseph Mikhael
Pageof 44

Showing results (61-70 of 440) with videos related to

Sort By:
Pageof 44
CA: a Cancer Journal for Clinicians|January 10, 2023
Chimeric antigen receptor T-cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practiceRujul H Parikh, Sagar Lonial
Cancer|May 19, 2016
Death by a thousand cuts: the slow demise of chemotherapyAjay K Nooka, Sagar Lonial
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
The era of combination therapy in myelomaSagar Lonial, Jonathan L Kaufman
Biologics : Targets & Therapy|February 13, 2016
Emerging treatments in Castleman disease - a critical appraisal of siltuximabJean L Koff, Sagar Lonial
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Novel drug combinations for the management of relapsed/refractory multiple myelomaSaad Z Usmani, Sagar Lonial
Current Opinion in Oncology|September 5, 2020
Practical approach to the management of smoldering myelomaNisha S Joseph, Sagar Lonial
Current Hematologic Malignancy Reports|May 8, 2010
Improving induction therapy in multiple myelomaAjay Nooka, Charise Gleason, Sagar Lonial
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2013
Induction therapy for newly diagnosed multiple myelomaSagar Lonial, Jesus F San Miguel
Current Hematologic Malignancy Reports|April 29, 2010
Treatment of relapsed and refractory myelomaJonathan Kaufman, Charise Gleason, Sagar Lonial
Journal of the National Medical Association|December 24, 2022
Disparities in multiple myeloma among African AmericansManisha Bhutani, Sagar Lonial, Joseph Mikhael
Pageof 44